ARCHIVES OF MEDICAL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2015-03-14 b2007117

Archives of medical research
NLM 缩写： Arch Med Res
NLM ID： 9312706
出版国家： United States
出版地： New York, NY
出版商： Elsevier Science
出版周期： Eight no. a year,
创刊年份： 1992
语言：英语
SCI收录： YES

ISSN： 0188-4409 (印刷版)
1873-5487 (电子版)
0188-4409 (ISSNLinking)
目前收录于： IM
PubMed收录： YES
研究领域：医学
审稿速度：平均81天
见刊速度：平均137天

484 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2022-04-26 jincq2008

大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma
From: editor@esmedjournals.org
Sent: Wednesday, April 20, 2022
To: ****@163.com
Subject: ssthma research?

Dear Dr. ****,

I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this.

Could we discuss this idea?

Sincerely,

Pulmonology Editorial Committee
Medical Research Archives
European Society of Medicine
Online ISSN: 2375-1924
Print ISSN: 2375-1916
PubMed ID: 101668511

50 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2022-07-14 krygios

这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2023-09-16 kiran123kz

这个杂志目前被踢出SCI了吗？什么情况？可以投吗

21 0

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2023-03-16 ms8000001626454432 来自湖北省

4个月了才告诉我找不到审稿人

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2023-02-28 14719d30m62暂无昵称来自山东省

真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了......
1.说要提供ORCID 也没有填写的地方啊
2.需要描述作者贡献，是直接在这个 word form 上写吗？

23 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2022-10-01 ms9000000993406142

请问Author Agreement在哪里下载还是需要自己写

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2017-03-10 JPDXQ

各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？

298 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2019-11-13 lovell

请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表:
2017年11月9日 submit
2018年1月16日 major revision
2018年2月23日re-submit（返修后投稿状态一直是with Editor）
2018年3月26日2nd-revision（通过邮箱返修）
2018年4月6日accept

Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit
2018年1月16日 major revision
2018年2月23日re-submit（返修后投稿状态一直是with Editor）
2018年3月26日2nd-revision（通过邮箱返修）
2018年4月6日accept

225 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=510479, encodeId=143b5104e904, content=Archives of medical research NLM 缩写： Arch Med Res NLM ID： 9312706 出版国家： United States 出版地： New York, NY 出版商： Elsevier Science 出版周期： Eight no. a year, 创刊年份： 1992 语言：英语 SCI收录： YES ISSN： 0188-4409 (印刷版) 1873-5487 (电子版) 0188-4409 (ISSNLinking) 目前收录于： IM PubMed收录： YES 研究领域：医学 审稿速度：平均81天 见刊速度：平均137天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=484, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=85f118338, createdName=b2007117, createdTime=Sat Mar 14 17:14:00 CST 2015, time=2015-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214388, encodeId=0bcb12143882c, content=大家鉴定一下这个邮件是假的吗？感觉不是真的，题目asthma给写成了ssthma From: editor@esmedjournals.org Sent: Wednesday, April 20, 2022 To: ****@163.com Subject: ssthma research? Dear Dr. ****, I wanted to get in contact with you regarding your Asthma research. I am helping to assemble a special theme issue on Trends & Innovations in Asthma which will be published by the European Society of Medicine later this year. I thought that it might be interesting to include an article related to your work on "****" in the theme issue. It would be great if you could tell me more about your work on this. Could we discuss this idea? Sincerely, Pulmonology Editorial Committee Medical Research Archives European Society of Medicine Online ISSN: 2375-1924 Print ISSN: 2375-1916 PubMed ID: 101668511, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=716180314, createdName=jincq2008, createdTime=Tue Apr 26 07:18:52 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232379, encodeId=7c0712323e9af, content=这个杂志太慢了，看到track系统，一个半月了才只有一个审稿人同意审稿，这个审稿人过了20天审稿也没完成，而且还是发催稿的情况下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Thu Jul 14 09:20:59 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157987, encodeId=6fce215e9879b, content=这个杂志目前被踢出SCI了吗？什么情况？可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dadb1484532, createdName=kiran123kz, createdTime=Sat Sep 16 11:51:11 CST 2023, time=2023-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120027, encodeId=473b212002ec8, content=4个月了才告诉我找不到审稿人 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78558363945, createdName=ms8000001626454432, createdTime=Thu Mar 16 21:00:50 CST 2023, time=2023-03-16, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2116872, encodeId=c85021168e299, content=真诚地求教各位老师，在作者指南里下载的它提交要求的 authorship agreement form 到底是怎么填的，我填了好几次都被退回来了...... 1.说要提供ORCID 也没有填写的地方啊 2.需要描述作者贡献，是直接在这个 word form 上写吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d97e5191408, createdName=14719d30m62暂无昵称, createdTime=Tue Feb 28 11:48:56 CST 2023, time=2023-02-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2091353, encodeId=0ffd2091353bd, content=请问Author Agreement在哪里下载还是需要自己写, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6aa28356358, createdName=ms9000000993406142, createdTime=Sat Oct 01 16:48:47 CST 2022, time=2022-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534001, encodeId=f7a95340019b, content=各位前辈，我做的是肺纤维化动物实验的基础研究，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:20:00 CST 2017, time=2017-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579774, encodeId=0d315e97741d, content=请问这个杂志要收版面费嘛，大约多少钱Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , beContent=Doctor XiaoSa 2018-04-16 15:15:00 发表: 2017年11月9日 submit 2018年1月16日 major revision 2018年2月23日re-submit（返修后投稿状态一直是with Editor） 2018年3月26日2nd-revision（通过邮箱返修） 2018年4月6日accept , objectType=tool_impact_factor, channel=null, level=null, likeNumber=225, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579776, encodeId=08845e97766b, content=这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , beContent=superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿 2012.2.24 投稿 2012.3.21 under review 2012.5.15 major revision 2012.6.15 re-submission 2012.7.25 2nd-revision 2012.7.31 re-re-submission 2012.8.10 accept 碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运 , objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8351626980, createdName=lovell, createdTime=Wed Nov 13 00:00:00 CST 2019, time=2019-11-13, status=1, ipAttribution=)]

2019-11-13 lovell

这个杂志版面费高吗superalert 2012-08-11 08:30:00 发表:
刚才忘记登录啦，嘿嘿

2012.2.24 投稿
2012.3.21 under review
2012.5.15 major revision
2012.6.15 re-submission
2012.7.25 2nd-revision
2012.7.31 re-re-submission
2012.8.10 accept
碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运

superalert 2012-08-11 08:30:00 发表: 刚才忘记登录啦，嘿嘿

2012.2.24 投稿
2012.3.21 under review
2012.5.15 major revision
2012.6.15 re-submission
2012.7.25 2nd-revision
2012.7.31 re-re-submission
2012.8.10 accept
碰上了一个比较钻牛角尖的审稿人，还是R1，第一次修稿后，R2和R3已经没有意见，R1却始终纠结于某个不是问题的问题，第二次修稿时给编辑和R1回复了很长很长的信，用老板的话说有点像吵架，第二次修稿并没有再次送审，在编辑那儿放了10天，直接接收了。这个杂志整体感觉还行，只要认真回复审稿人提出的意见，有些意见即使解决不了，但你只要回答的有道理，编辑一般还是不错的，基本都会接收。该杂志审稿周期属于不快不慢，就说这么多吧，嘿嘿，祝大家好运

126 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务